Central Alerting System
View Alert


Originator: MHRA Drug Alerts

From: Alison Bunce - Medicines and Healthcare Products Regulatory Agency

Issue date: 04-Feb-2019 14:00:06

This alert has been issued to:
  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • NHS Regional Offices
  • NHS Foundation Trusts (England) - Medical Director
  • NHS Trusts (England) - Medical Director
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • Regional Directors of Public Health

  • Clinical Commissioning Groups
  • NHS Foundation Trusts (England) - Chief Executive
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • Director of Public Health
  • NHS Trusts (England) - Chief Executive

Action category: Class 4: For information

Title: DRUG ALERT CLASS 4, FOR INFORMATION, ACCORD HEALTHCARE LIMITED, AMOXICILLIN 500MG CAPSULES BP

Broadcast content: Issue of a 'Caution in Use' notification regarding the late implementation of the updated Patient Information Leaflet (PIL) for certain batches of the above product. 

NB It is not necessary to forward this Drug Alert to non-dispensing GPs.


Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-device-alerts 



Alert reference: EL (19)A/03

Attachments:
Cascade to:
  • #COMMUNITYPHARMACISTS#
  • #DISPENSING GP#


Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency